Testing and reducing Skindex-29 using rasch analysis: Skindex-17

Journal of Investigative Dermatology

Volumn 126, Issue 6, 2006, Pages 1244-1250

  Nijsten, Tamar E C ^a   Sampogna, Francesca ^b   Chren, Mary Margaret ^c   Abeni, Damiano D ^b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b LABORATORIO DI PATOLOGIA VASCOLARE   (Italy)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; DERMATOLOGY; EMOTION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; PRIORITY JOURNAL; PSYCHOMETRY; QUALITY OF LIFE; RASCH ANALYSIS; SCORING SYSTEM; SKINDEX 17; SOCIAL PSYCHOLOGY; SOCIAL STATUS; DERMATITIS; METHODOLOGY; MIDDLE AGED; PSYCHOLOGICAL ASPECT; QUESTIONNAIRE; VALIDATION STUDY;

ADULT; DERMATITIS; FEMALE; HUMANS; MALE; MIDDLE AGED; PSYCHOMETRICS; QUALITY OF LIFE; QUESTIONNAIRES;

EID: 33745532043     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/sj.jid.5700212     Document Type: Article

References (35)

1. Abeni D, Picardi A, Pasquini P, Melchi CF, Chren MM (2002) Further evidence of the validity and reliability of the Skindex-29: an Italian study on 2,242 dermatological outpatients. Dermatology 204:43-9
2. Abeni D, Picardi A, Puddu P, Pasquini P, Chren MM (2001) Construction and validation of the Italian version of Skindex-29, a new instrument to measure quality of life in dermatology (in Italian, abstract in English). G Ital Dermatol Venereol 136:73-6
3. Angoff WH (1993) Perspectives on differential item functioning methodology. In: Differential item functioning (Holland PW, Wainer H, eds), Hillsdale, NJ: Lawrence Erlbaum
4. Augustin M, Wenninger K, Amon U, Schroth MJ, Kuster W, Chren M et al. (2004) German adaptation of the Skindex-29 questionnaire on quality of life in dermatology: validation and clinical results. Dermatology 209:14-20
5. Boehning DB, Schlattmann P (2005) Computer assisted analysis of mixtures (C.A.MAN). Available at: ftp.ukbf.fu-berlin.de/sozmed/caman.html (accessed 20 August)
6. Bullinger M, Anderson R, Cella D, Aaronson N (1993) Developing and evaluating cross-cultural instruments from minimum requirements to optimal models. Qual Life Res 12:451-9
7. Chren MM (1999) Understanding research about quality of life and other health outcomes. J Cutan Med Surg 3:312-6
8. Chren MM, Lasek RJ, Sahay AP, Sands LP (2001) Measurement properties of Skindex-16: a brief quality-of-life measure for patients with skin diseases. J Cutan Med Surg 5:105-10
9. Chren MM (2005) Measurement of vital signs of skin diseases. J Invest Dermatol 125:vii-ix
10. Chren MM, Lasek RJ, Flocke SA, Zyzanski SJ (1997) Improved discriminative and evaluative capability of a refined version of Skindex, a quality-of-life instrument for patients with skin diseases. Arch Dermatol 133:1433-40
11. Chren MM, Lasek RJ, Quinn LM, Mostow EN, Zyzanski SJ (1996) Skindex, a quality-of-life measure for patients with skin disease: reliability, validity, and responsiveness. J Invest Dermatol 107:707-13
12. Coste J, Guillemin F, Pouchot J, Fermanian J (1997) Methodological approaches to shortening composite measurement scales. J Clin Epidemiol 50:247-52
13. de Jong Z, van der Heijde D, McKenna SP, Whalley D (1997) The reliability and construct validity of the RAQoL: a rheumatoid arthritis-specific quality of life instrument. Br J Rheumatol 36:878-83
14. Guillemin F, Bombardier C, Beaton D (1993) Cross-cultural adaptation of health-related quality of life measures: literature review and proposed guidelines. J Clin Epidemiol 46:1417-32
15. Guyatt GH, Osoba D, Wu AW, Wyrwich KW, Norman GR, Clinical Significance Consensus Meeting Group (2002) Methods to explain the clinical significance of health status measures. Mayo Clin Proc 77:371-83
16. Haughton D (1997) Packages for estimating finite mixtures: a review. Am Stat 51:194-204
17. Hemingway H, Stafford M, Stansfeld S, Shipley M, Marmot M (1997) Is the SF-36 a valid measure of change in population health? Results from the Whitehall II Study. BMJ 315:1273-9
18. Houssien DA, McKenna SP, Scott DL (1997) The Nottingham Health Profile as a measure of disease activity and outcome in rheumatoid arthritis. Br J Rheumatol 36:69-73
19. McHorney CA (1997) Generic health measurement: past accomplishments and a measurement paradigm for the 21st century. Ann Intern Med 127:743-50
20. McKenna SP, Cook SA, Whalley D, Doward LC, Richards HL, Griffiths CE et al. (2003) Development of the PSORIQoL, a psoriasis-specific measure of quality of life designed for use in clinical practice and trials. Br J Dermatol 149:323-31
21. Michell J (1997) Quantitative science and the definition of measurement in psychology. Br J Psychol 88:355-83
22. Michell J (2003) Measurement: a beginner's guide. J Appl Meas 4:298-308
23. Nijsten T, Unaeze J, Stern RS (2006) Refinement and reduction of the Impact of Psoriasis Questionnaire: classical test theory vs Rasch analysis. Br J Dermatol. 16 January [E-pub ahead of print, doi:10.1111/j.1365-2133.2005.07066. X]
24. Nijsten T, Whalley D, Gelfand J, Margolis DJ, McKenna SP, Stern RS (2005) The psychometric properties of the Psoriasis Disability Index in United States patients. J Invest Dermatol 125:665-72
25. Piccinelli M, Bisoffi C, Bon MC, Cunico L, Tansella M (1993) Validity and test-retest reliability of the Italian version of the 12-item General Health Questionnaire in general practice: a comparison between three scoring methods. Compr Psychiatry 34:198-205
26. Prieto L, Alonso J, Lamarca R (2003) Classical test theory versus Rasch analysis for quality of life questionnaire reduction. Health Qual Life Outcomes 1:27
27. Rasch G (1960) Probabilistic models for some intelligence and attainment tests. Chicago: University of Chicago Press (reprinted, 1980)
28. Sampogna F, Sera F, Abeni D, IDI Multipurpose Psoriasis Research on Vital Experiences (IMPROVE) Investigators (2004) Measures of clinical severity, quality of life, and psychological distress in patients with psoriasis: a cluster analysis. J Invest Dermatol 122:602-7
29. Stevens SS (1946) On the theory of scales. Science 103:677-88
30. Streiner DL, Norman GF (2003) Health measurement scales: a practical guide to their development and use. 3rd edn. Oxford: Oxford University Press
31. Tennant A, McKenna SP, Hagell P (2004a) Application of Rasch analysis in the development and application of quality of life instruments. Value Health 7:S22-6
32. Tennant A, Penta M, Tesio L et al. (2004b) Assessing and adjusting for cross-cultural validity of impairment and activity limitation scales through differential item functioning within the framework of the Rasch model: the PRO-ESOR project. Med Care 42:137-48
33. Tesio L (2003) Measuring behaviours and perceptions: Rasch analysis as a tool for rehabilitation research. J Rehabil Med 35:105-15
34. Unaeze J, Nijsten T, Murphy A, Ravichandran C, Stern RS (in press) Impact of psoriasis on health related quality of life decrease over time: an 11-year prospective study. J Invest Dermatol
35. Whalley D, McKenna SP, Dewar AL, Erdman RA, Kohlmann T, Niero M et al. (2004) A new instrument for assessing quality of life in atopic dermatitis: international development of the Quality of Life Index for Atopic Dermatitis (QoLIAD). Br J Dermatol 150:274-83